Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02168179 | KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT03045393 | Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC(IMGN853) | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT02331212 | Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer | withdrawn | — | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT01542203 | Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer | withdrawn | — | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT01134497 | Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer(PLANET) | withdrawn | Phase 2 | 0 | Cardiff UniversityOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT00006123 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Beth Israel Deaconess Medical CenterOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT02505698 | A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment | withdrawn | — | 0 | Real Imaging Ltd.INDUSTRY | 1 | Apr 11, 2018 | clinicaltrials |
| NCT02103946 | Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia(SAM) | withdrawn | N/A | 0 | National Cancer Institute, EgyptOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT00328354 | Mammography SPECT With Rotating Slant Hole Collimator | withdrawn | — | 0 | Johns Hopkins UniversityOTHER | 1 | Apr 6, 2018 | clinicaltrials |
| NCT01796444 | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node(Z0011-China) | withdrawn | Phase 3 | 0 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02269696 | The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients | withdrawn | Phase 3 | 0 | Kuopio University HospitalOTHER | 0 | Mar 22, 2018 | clinicaltrials |
| NCT03081234 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer(EarLEE-2) | withdrawn | Phase 3 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 15, 2018 | clinicaltrials |
| NCT01710293 | Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis(PACT CREATE 3) | withdrawn | N/A | 0 | VA Office of Research and DevelopmentFED | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device(PICC One Day) | withdrawn | Phase 3 | 0 | Centre Leon BerardOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT00610831 | Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD) | withdrawn | N/A | 0 | University of California, IrvineOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03126487 | High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer(MRHEATBREAST) | withdrawn | N/A | 0 | Centre Antoine LacassagneOTHER | 1 | Jan 29, 2018 | clinicaltrials |
| NCT01972048 | Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening | withdrawn | N/A | 0 | University of MinnesotaOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | withdrawn | Phase 1 / Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 13, 2017 | clinicaltrials |
| NCT00373152 | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer | withdrawn | Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 5, 2017 | clinicaltrials |
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | withdrawn | Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Dec 2, 2017 | clinicaltrials |
| NCT01724242 | Vaginal DHEA for Women After Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Hadassah Medical OrganizationOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT02752009 | Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 0 | Nov 21, 2017 | clinicaltrials |
| NCT02944721 | Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer(DOLORISKSEIN) | withdrawn | N/A | 0 | Hopital FochOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT00722683 | Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts | withdrawn | N/A | 0 | University of MichiganOTHER | 1 | Oct 18, 2017 | clinicaltrials |
| NCT03032614 | Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Oct 10, 2017 | clinicaltrials |
| NCT02768714 | Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy | withdrawn | Phase 3 | 0 | Eurofarma Laboratorios S.A.INDUSTRY | 0 | Sep 15, 2017 | clinicaltrials |
| NCT00899145 | Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers | withdrawn | — | 0 | Gynecologic Oncology GroupNETWORK | 1 | Jul 13, 2017 | clinicaltrials |
| NCT02651610 | Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01936961 | Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors(I-CREST) | withdrawn | N/A | 0 | Western Regional Medical CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT02915172 | Lenvatinib and Capecitabine in Patients With Advanced Malignancies | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2017 | clinicaltrials |
| NCT02483871 | Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Jun 5, 2017 | clinicaltrials |
| NCT01361945 | AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Texas Tech University Health Sciences Center, El PasoOTHER | 0 | May 9, 2017 | clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02621099 | Hybrid Gamma Camera in Breast Surgery(HICAM) | withdrawn | — | 0 | University of NottinghamOTHER | 1 | May 5, 2017 | clinicaltrials |
| NCT01227408 | Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT01029977 | Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology | withdrawn | — | 0 | Real Imaging Ltd.INDUSTRY | 1 | Apr 27, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT00397501 | BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain | withdrawn | Phase 1 / Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Apr 21, 2017 | clinicaltrials |
| NCT01681901 | Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography | withdrawn | — | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Apr 13, 2017 | clinicaltrials |
| NCT01729832 | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer | withdrawn | N/A | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Apr 13, 2017 | clinicaltrials |
| NCT02067637 | Delayed Effects of Treatment in Cancer Survivors (DETECS)(DETECS) | withdrawn | — | 0 | University of Colorado, DenverOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT02685306 | A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer | withdrawn | Phase 2 | 0 | Peregrine PharmaceuticalsINDUSTRY | 0 | Mar 9, 2017 | clinicaltrials |
| NCT01302821 | C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT02616224 | A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | withdrawn | — | 0 | Hoffmann-La RocheINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT01640847 | MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases | withdrawn | Phase 2 | 0 | ImunonINDUSTRY | 0 | Feb 7, 2017 | clinicaltrials |
| NCT00695916 | MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery | withdrawn | Phase 3 | 0 | Stanford UniversityOTHER | 0 | Feb 1, 2017 | clinicaltrials |
| NCT01780532 | Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jan 30, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 5, 2018source: clinicaltrials